Efficacy of denbufylline in patients with multi‐infarct dementia

Drug Development Research

Volumn 14, Issue 3-4, 1988, Pages 195-198

  O'Connolly, M ^a   Dierdorf, D ^a   Greb, W H ^a   Mayer, M E R ^a   Wolf, D ^a  

^a Beecham‐Wülfing GmbH & CoKG ^*  (Germany)

Author keywords

cerebrovascular disease; clinical study; psychometric testing

Indexed keywords

DENBUFYLLINE; PLACEBO;

CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL FLICKER FUSION; DOUBLE BLIND PROCEDURE; DRUG TOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0024155069     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.430140307     Document Type: Article

References (3)

1. Denbufylline ‐ a novel drug to alleviate the consequences of cerebral ischemia
2. The effect of denbufylline in passive avoidance trials in gerbils—following trans‐forebrain ischemia—and in mice
3. Efficacy and tolerance of denbufylline in patients with cerebrovascular disease ‐ an investigational study with a new agent